Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health
Search Results for: Johnson
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings
Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an
Earnings Summary: A snapshot of Johnson Controls (JCI) Q4 2023 results
Johnson Controls International plc (NYSE: JCI), a provider of sustainable building solutions, announced results for the fourth quarter and fiscal 2023. It
Johnson & Johnson (JNJ) focuses on innovation after separating consumer business
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Johnson & Johnson to report earnings on Oct 17. Here’s what to look for
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net
Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move is part
Johnson Outdoors Inc (JOUT) Q2 2023 Earnings Call Transcript
Johnson Outdoors Inc (NASDAQ:JOUT) Q2 2023 Earnings Call dated May. 05, 2023. Corporate Participants: Patricia Penman -- Vice President of Marketing Services & Global
Johnson Controls International plc (JCI) Q2 2023 Earnings Call Transcript
Johnson Controls International plc (NYSE:JCI) Q2 2023 Earnings Call dated May. 05, 2023. Corporate Participants: Jim Lucas — Vice President, Investor Relations George Oliver — Chairman
Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J.
JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today. Reported sales increased 5.6% year-over-year to $24.7 billion. On a
Johnson Outdoors Inc (JOUT) Q1 2023 Earnings Call Transcript
Johnson Outdoors Inc (NASDAQ: JOUT) Q1 2023 earnings call dated Feb. 03, 2023 Corporate Participants: Patricia Penman -- Vice President, Marketing Services and Global
Johnson Controls International plc (JCI) Q1 2023 Earnings Call Transcript
Johnson Controls International plc (NYSE: JCI) Q1 2023 earnings call dated Feb. 01, 2023 Corporate Participants: Jim Lucas -- Vice President, Investor Relations Olivier Leonetti -- Chief
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today. Reported sales decreased 4.4% year-over-year to $23.7 billion. Net
Johnson Controls International plc (JCI) Q4 2022 Earnings Call Transcript
Johnson Controls International plc (NYSE:JCI) Q4 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Michael Gates -- Senior Director of Investor Relations George
JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales
Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase in net